UBE2G1

gene product
UBC7, UBE2G
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family and catalyzes the covalent attachment of ubiquitin to other proteins. The protein may be involved in degradation of muscle-specific proteins. [provided by RefSeq, Jul 2008]
More gene data

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
203 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
79 antibodies
Proteintech Group
1 antibody
Novus Biologicals
5 antibodies
Abnova Corporation
5 antibodies
Invitrogen Antibodies
6 antibodies
Acris Antibodies GmbH
6 antibodies
NovoPro Bioscience Inc.
2 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
8 antibodies
Abgent
4 antibodies
Aviva Systems Biology
3 antibodies
GeneTex
1 antibody
OriGene
1 antibody
LifeSpan BioSciences, Inc.
40 antibodies
St John's Laboratory
2 antibodies
Affinity Biosciences
1 antibody
RabMAbs
1 antibody
MyBioSource
4 antibodies
Boster Biological Technology
1 antibody
ProSci
1 antibody
RayBiotech, Inc.
1 antibody
Sigma-Aldrich
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Creative Biolabs
1 antibody
United States Biological
13 antibodies